株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の体外診断薬市場:セグメント別、製品別、企業別予測

United States In Vitro Diagnostics Market, Forecast by IVD Segments, Products, Companies

発行 Renub Research 商品コード 825610
出版日 ページ情報 英文 225 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.13円で換算しております。
Back to Top
米国の体外診断薬市場:セグメント別、製品別、企業別予測 United States In Vitro Diagnostics Market, Forecast by IVD Segments, Products, Companies
出版日: 2019年04月24日 ページ情報: 英文 225 Pages
概要

当レポートでは、米国の体外診断薬市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 体外診断薬市場

第4章 市場シェア

  • セグメント別
  • 製品別
  • 地域別

第5章 セグメント別市場

  • 臨床化学
  • 微生物学
  • ポイントオブケア
  • 免疫測定
  • 尿検査
  • 凝固
  • 組織学
  • 血液学
  • 血液検査、血液型検査
  • フローサイトメトリ

第6章 製品別市場

  • サービス
  • ソフトウェア
  • 試薬
  • 計器

第7章 地域別市場

  • 南部
  • 西部
  • 中西部
  • 北東部

第8章 市場動向

  • 成長促進因子
    • 慢性疾患、感染症の増加
    • 技術進歩
    • 高齢化
  • 課題
    • 厄介な償還手続き
    • ラボ技術者の不足

第9章 企業分析

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation
図表

List of Figures:

  • Figure-01: United States IVD Market (Million US$), 2013 - 2018
  • Figure-02: Forecast for United States IVD Market (Million US$), 2019 - 2024
  • Figure-03: United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2013 - 2018
  • Figure-04: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2019 - 2024
  • Figure-05: United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2013 - 2018
  • Figure-06: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2019 - 2024
  • Figure-07: United States In-Vitro Diagnostics (IVD) Market Share (%) by Regions, 2019 - 2024
  • Figure-08: Forecast for Delivery Models - India Online Food Delivery Market Share (%) 2019 - 2023
  • Figure-09: United States - In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2013 - 2018
  • Figure-10: United States - Forecast for In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2019 - 2024
  • Figure-11: United States - In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2013 - 2018
  • Figure-12: United States - Forecast for In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2019 - 2024
  • Figure-13: United States - In-Vitro Diagnostics Market by Microbiology - Molecular (Million US$), 2013 - 2018
  • Figure-14: United States - Forecast for In-Vitro Diagnostics Market by Microbiology - Molecular (Million US$), 2019 - 2024
  • Figure-15: United States - In-Vitro Diagnostics Market by POC - Professional (Million US$), 2013 - 2018
  • Figure-16: United States - Forecast for In-Vitro Diagnostics Market by POC - Professional (Million US$), 2019 - 2024
  • Figure-17: United States - In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2013 - 2018
  • Figure-18: United States - Forecast for In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2019 - 2024
  • Figure-19: United States - In-Vitro Diagnostics Market by POC - Others (Million US$), 2013 - 2018
  • Figure-20: United States - Forecast for In-Vitro Diagnostics Market by POC - Others (Million US$), 2019 - 2024
  • Figure-21: United States - In-Vitro Diagnostics Market by Immunoassay - Infectious (Million US$), 2013 - 2018
  • Figure-22: United States - Forecast for In-Vitro Diagnostics Market by Immunoassay - Infectious (Million US$), 2019 - 2024
  • Figure-23: United States - In-Vitro Diagnostics Market by Immunoassay - Others (Million US$), 2013 - 2018
  • Figure-24: United States - Forecast for In-Vitro Diagnostics Market by Immunoassay - Others (Million US$), 2019 - 2024
  • Figure-25: United States - In-Vitro Diagnostics Market by Urinalysis (Million US$), 2013 - 2018
  • Figure-26: United States - Forecast for In-Vitro Diagnostics Market by Urinalysis (Million US$), 2019 - 2024
  • Figure-27: United States - In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2013 - 2018
  • Figure-28: United States - Forecast for In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2019 - 2024
  • Figure-29: United States - In-Vitro Diagnostics Market by Coagulation (Million US$), 2013 - 2018
  • Figure-30: United States - Forecast for In-Vitro Diagnostics Market by Coagulation (Million US$), 2019 - 2024
  • Figure-31: United States - In-Vitro Diagnostics Market by Histology (Million US$), 2013 - 2018
  • Figure-32: United States - Forecast for In-Vitro Diagnostics Market by Histology (Million US$), 2019 - 2024
  • Figure-33: United States - In-Vitro Diagnostics Market by Hematology (Million US$), 2013 - 2018
  • Figure-34: Forecast for Online Food Delivery Market By Hematology (Million US$), 2019 - 2025
  • Figure-35: United States - In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2013 - 2018
  • Figure-36: United States - Forecast for In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2019 - 2024
  • Figure-37: United States - In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2013 - 2018
  • Figure-38: United States - Forecast for In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2019 - 2024
  • Figure-39: United States In-Vitro Diagnostics Products Market by Services (Million US$), 2013 - 2018
  • Figure-40: United States - Forecast for In-Vitro Diagnostics Products Market by Services (Million US$), 2019 - 2024
  • Figure-41: United States In-Vitro Diagnostics Products Market by Software (Million US$), 2013 - 2018
  • Figure-42: United States - Forecast for In-Vitro Diagnostics Products Market by Software (Million US$), 2019 - 2024
  • Figure-43: United States In-Vitro Diagnostics Products Market by Reagents (Million US$), 2013 - 2018
  • Figure-44: United States - Forecast for In-Vitro Diagnostics Products Market by Reagents (Million US$), 2019 - 2024
  • Figure-45: United States In-Vitro Diagnostics Products Market by Instruments (Million US$), 2013 - 2018
  • Figure-46: United States - Forecast for In-Vitro Diagnostics Products Market by Instruments (Million US$), 2019 - 2024
  • Figure-47: United States In-Vitro Diagnostics Market by South Regions (Million US$), 2013 - 2018
  • Figure-48: United States - Forecast for In-Vitro Diagnostics Market by South Regions (Million US$), 2019 - 2024
  • Figure-49: United States In-Vitro Diagnostics Market by West Regions (Million US$), 2013 - 2018
  • Figure-50: United States - Forecast for In-Vitro Diagnostics Market by West Regions (Million US$), 2019 - 2024
  • Figure-51: United States In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2013 - 2018
  • Figure-52: United States - Forecast for In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2019 - 2024
  • Figure-53: United States In-Vitro Diagnostics Market by North East Regions (Million US$), 2013 - 2018
  • Figure-54: United States - Forecast for In-Vitro Diagnostics Market by North East Regions (Million US$), 2019 - 2024
  • Figure-55: Prevalence of Chronic Disease in United States (1995 - 2030)
  • Figure-56: Global - Population aged 65 & Over, (in Millions), 2015, 2030 & 2050
  • Figure-57: Roche Diagnostics - Global Sales (Million US$), 2014 - 2018
  • Figure-58: Roche Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
  • Figure-59: Abbott Diagnostics - Global Sales (Million US$), 2014 - 2018
  • Figure-60: Abbott Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
  • Figure-61: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2015 - 2018
  • Figure-62: Siemens Healthineers - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-63: Danaher Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-64: Danaher Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-65: Thermo Fisher Scientific - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-66: Thermo Fisher Scientific - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
  • Figure-67: Sysmex Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure-68: Sysmex Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
目次

In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. In Vitro Diagnostics has proven itself to be the best diagnostic procedures in managing the chronic diseases. IVDs help in the early detection of patient's health condition and risk associated with it, creating new opportunities for the early intervention and prevention. United States In-Vitro Diagnostics (IVD) Market is the largest IVD market across the world and is also the leading consumer of the IVD market. IVD market increasingly is subject to demands for improved diagnosis and quality test results of patient's ailments. In Vitro Diagnostics help in responding such demands by enabling accurate detection of diseases and health risks at the earlier stages, aid in improved treatment and disease management, further diminishing the subsequent health risks and their associated cost. United States In Vitro Diagnostics (IVD) market is expected to be more than US$ 35 Billion by the end of year 2024.

In the United States, some of the common diagnostic tests conducted include cholesterol level tests, blood sugar tests, HIV tests, pap tests, tests for infectious diseases, hCG (pregnancy) tests and substance abuse tests. Some of the major factors stimulating the growth of the United States IVD market include a high incidence of chronic diseases, increasing preference for Point of Care (POC) diagnostics, technological advancements in the field of diagnostics and increasing awareness and acceptance regarding personalized medicine. In addition; government favorable healthcare policy, better healthcare infrastructure and increasing consumer's healthcare expenditure for seeking quality healthcare further helps United States IVD Market to grow effortlessly over the forecast period.

Renub Research report titled "United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology -ID/AST, Microbiology - Molecular, POC - Professional, POC - OTC Diabetes, POC - Others, Immunoassay - Infectious, Immunoassay - Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry), Products (Services, Software, Reagents, Instruments) Regions (South, West, Midwest, North East), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)" provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.

Point of Care Testing market dominates United States In-Vitro Diagnostics (IVD) Market

United States In Vitro Diagnostics (IVD) Market is segmented into Clinical chemistry, Microbiology -ID/AST, Microbiology - Molecular, POC - Professional, POC - OTC Diabetes, POC - Others, Immunoassay - Infectious, Immunoassay - Others, Urinalysis, Molecular - Non Infectious, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry. Point of care testing market dominates the United States In-Vitro Diagnostics (IVD) market.

Instruments and Reagents are leading Products in the United States In-Vitro Diagnostics (IVD) Market

On the basis of products, United States In-Vitro Diagnostics (IVD) market is segmented into service, software, instruments and reagents. Instruments and reagents are top two leading products in the United States In-Vitro Diagnostics (IVD) market.

South Region holds impressive share in the United States In-Vitro Diagnostics (IVD) Market

In this report, we have categorized the United States In-Vitro Diagnostics (IVD) market into four regions; South, West, Midwest, North East. It is anticipated that South and West regions plays the significant role in the United States In-Vitro Diagnostics (IVD) market during the forecast period of 2019-2024.

Company Analysis

Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies operating in the In-Vitro Diagnostics segment globally. All the companies have been studied from three points:

  • Overview
  • Initiatives & Recent Developments
  • Sales

By Segments - United States In-Vitro Diagnostics (IVD) Market:

  • 1. Clinical chemistry
  • 2. Microbiology -ID/AST
  • 3. Microbiology - Molecular
  • 4. POC - Professional
  • 5. POC - OTC Diabetes
  • 6. POC - Others
  • 7. Immunoassay - Infectious
  • 8. Immunoassay - Others
  • 9. Urinalysis
  • 10. Molecular - Non Infectious
  • 11. Coagulation
  • 12. Histology
  • 13. Hematology
  • 14. Blood Testing and Typing
  • 15. Flow Cytometry

By Products - United States In-Vitro Diagnostics (IVD) Market:

  • Services
  • Software
  • Reagents
  • Instruments

By Regions - United States In-Vitro Diagnostics (IVD) Market:

  • South
  • West
  • Midwest
  • North East

Company covered in this report:

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation

Table of Contents

1.. Introduction

2.. Research & Methodology

3.. United States In-Vitro Diagnostics (IVD) Market

4.. Market Share - United States In-Vitro Diagnostics (IVD) Analysis

  • 4.1. By Segments
  • 4.2. By Products
  • 4.3. By Regions

5.. Segments - United States In-Vitro Diagnostics (IVD) Market

  • 5.1. Clinical Chemistry
  • 5.2. Microbiology -ID/AST
  • 5.3. Microbiology - Molecular
  • 5.4. POC - Professional
  • 5.5. POC - OTC Diabetes
  • 5.6. POC - Others
  • 5.7. Immunoassay - Infectious
  • 5.8. Immunoassay - Others
  • 5.9. Urinalysis
  • 5.10. Molecular - Non Infectious
  • 5.11. Coagulation
  • 5.12. Histology
  • 5.13. Hematology
  • 5.14. Blood Testing and Typing
  • 5.15. Flow Cytometry

6.. Products - United States In-Vitro Diagnostics (IVD) Market

  • 6.1. Services
  • 6.2. Software
  • 6.3. Reagents
  • 6.4. Instruments

7.. Regions - United States In-Vitro Diagnostics (IVD) Market

  • 7.1. South
  • 7.2. West
  • 7.3. Midwest
  • 7.4. North East

8.. Market Dynamics

  • 8.1. Growth Drivers
    • 8.1.1. Growth in Chronic & Infectious Disease
    • 8.1.2. Technological Advances
    • 8.1.3. Aging Population
  • 8.2. Challenges
    • 8.2.1. Cumbersome Reimbursement Procedure
    • 8.2.2. Shortage of Lab Technicians

9.. Company Analysis

  • 9.1. Roche Diagnostics
    • 9.1.1. Overview
    • 9.1.2. Initiatives & Recent Developments
    • 9.1.3. Sales
  • 9.2. Abbott Diagnostics
    • 9.2.1. Overview
    • 9.2.2. Initiatives & Recent Developments
    • 9.2.3. Sales
  • 9.3. Siemens Healthineers
    • 9.3.1. Overview
    • 9.3.2. Initiatives & Recent Developments
    • 9.3.3. Sales
  • 9.4. Danaher Corporation
    • 9.4.1. Overview
    • 9.4.2. Initiatives & Recent Developments
    • 9.4.3. Sales
  • 9.5. Thermo Fisher Scientific
    • 9.5.1. Overview
    • 9.5.2. Initiatives & Recent Developments
    • 9.5.3. Sales
  • 9.6. Sysmex Corporation
    • 9.6.1. Overview
    • 9.6.2. Initiatives & Recent Developments
    • 9.6.3. Sales
Back to Top